
Obesity Clinical Trials
World Health Organization: INTERNATIONAL CLINICAL TRIALS REGISTRY PLATFORM SEARCH PORTAL
Simple or advanced search functions
Obesity News
Obesity Research
Obesity Blogs
Swivelchair is an anonymous biopharma worker who blogs about the neuroscience of dysfunctional human behavior.
![]()
E-mail me: Send Mail

A phytoalexin derived from grapes and other food products with antioxidant and potential chemopreventive activities. Resveratrol induces phase II drug-metabolizing enzymes (anti-initiation activity); mediates anti-inflammatory effects and inhibits cyclooxygenase and hydroperoxidase functions (anti-promotion activity); and induces promyelocytic leukemia cell differentiation (anti-progression activity), thereby exhibiting activities in three major steps of carcinogenesis. This agent may inhibit TNF-induced activation of NF-kappaB in a dose- and time-dependent manner. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
Chemical structure names: * (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzenediol * 3,4',5-stilbenetriol From Cancer.gov
Except where otherwise noted, content on this site is licensed under a Creative Commons Attribution 3.0 License
Neurological Correlates — Sitemap — Cutline by Chris Pearson © 2006–2007
0 responses so far ↓
There are no comments yet...Kick things off by filling out the form below.
Leave a Comment